News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
539,572 Results
Type
Article (37622)
Company Profile (116)
Press Release (501817)
Multimedia
Podcasts (154)
Webinars (32)
Section
Business (155597)
Career Advice (2900)
Deals (25370)
Drug Delivery (173)
Drug Development (64312)
Employer Resources (185)
FDA (13431)
Job Trends (11009)
News (243167)
Policy (24190)
Tag
2025 Best Places to Work (12)
2026 Best Places to Work (17)
2027 BioCapital Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (5)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Standard (3)
40 Under 40 (4)
Academia (2331)
Accelerated approval (64)
ADA (39)
Adcomms (26)
Allergies (189)
Alliances (36292)
ALS (231)
Alzheimer's disease (1674)
Antibody-drug conjugate (ADC) (606)
Approvals (14116)
Artificial intelligence (859)
ASCO (251)
Autoimmune disease (413)
Automation (69)
Bankruptcy (225)
Belgium (44)
Best Places to Work (9046)
BIO (65)
Biologics (107)
BIOSECURE Act (18)
Biosimilars (268)
BioSpace Insights (162)
Biotechnology (74)
Bispecific (59)
Bladder cancer (222)
Brain cancer (81)
Breast cancer (756)
Cancer (6285)
Cardiovascular disease (486)
Career advice (2493)
Career pathing (64)
CAR-T (319)
CDC (42)
CDMO (189)
Celiac Disease (7)
Cell-line development (1)
Cell therapy (894)
Cervical cancer (56)
Clinical research (58194)
Collaboration (2229)
Commercialization (65)
Company closure (3)
Compensation (1260)
Complete response letters (90)
COVID-19 (2400)
CRISPR (124)
CRO (9)
C-suite (1121)
Cystic fibrosis (155)
Data (9221)
Decentralized trials (3)
Denatured (38)
Depression (192)
Dermatology (171)
Diabetes (635)
Diagnostics (5856)
Digital health (66)
Diversity (12)
Diversity, equity & inclusion (41)
Drug discovery (394)
Drug pricing (171)
Drug shortages (25)
Duchenne muscular dystrophy (280)
Earnings (63000)
Editorial (76)
Employer branding (25)
Employer resources (163)
ESMO (317)
Events (86170)
Executive appointments (898)
Eye disease (25)
FDA (17589)
Fibrodysplasia Ossificans Progressiva (16)
Fragile X (5)
Friedreich's ataxia (22)
Frontotemporal dementia (37)
Funding (1700)
Gene editing (236)
Generative AI (69)
Gene therapy (702)
GLP-1 (1037)
Government (4349)
Grass and pollen (8)
Guidances (399)
Healthcare (14450)
Hematology (190)
HIV (96)
Huntington's disease (56)
Idiopathic pulmonary fibrosis (14)
IgA nephropathy (122)
Immunology and inflammation (267)
Immuno-oncology (115)
Indications (268)
Infectious disease (2749)
Inflammatory bowel disease (231)
Inflation Reduction Act (10)
Influenza (130)
Intellectual property (300)
Interviews (573)
IPO (12745)
IRA (41)
Job creations (2157)
Job search strategy (1991)
JPM (62)
Kidney cancer (27)
Kidney disease (147)
Labor market (136)
Layoffs (369)
Leadership (65)
Legal (4250)
Licensing (115)
Liver cancer (94)
Longevity (41)
Lung cancer (900)
Lung diease (23)
Lymphoma (478)
Machine learning (66)
Management (67)
Manufacturing (1205)
Marketing (40)
MASH (222)
Medical affairs (4)
Medical device (9890)
Medtech (10108)
Melanoma (177)
Mergers & acquisitions (13899)
Metabolic disorders (1602)
Middle East (2)
mRNA (259)
Multiple sclerosis (233)
Multispecific (5)
NASH (20)
Netherlands (36)
Neurodegenerative disease (464)
Neuropsychiatric disorders (113)
Neuroscience (3418)
Neurotech (3)
NextGen: Class of 2026 (5008)
Non-profit (3670)
Now hiring (87)
Obesity (689)
Opinion (359)
Ovarian cancer (223)
Pain (259)
Pancreatic cancer (334)
Parkinson's disease (379)
Partnered (40)
Patents (579)
Patient advocacy (7)
Patient recruitment (780)
Patient selection (106)
Peanut (62)
People (37511)
Peptides (40)
Pharmaceutical (38)
Pharmacy benefit managers (31)
Phase 1 (17359)
Phase 2 (25756)
Phase 3 (19964)
Pipeline (12210)
Policy (306)
Postmarket research (1796)
Preclinical (7289)
Press Release (46)
Prostate cancer (329)
Psychedelics (67)
Radioligand (1)
Radiopharmaceuticals (321)
Rare diseases (1280)
Real estate (3572)
Recruiting (78)
Regenerative medicine (25)
Regulatory (21598)
Reports (75)
Research institute (2060)
Resumes & cover letters (471)
Rett syndrome (34)
RNA editing (23)
RSV (77)
Saudi Arabia (1)
Schizophrenia (199)
Series A (297)
Series B (200)
Series C (1)
Service/supplier (6)
Sickle cell disease (123)
Special edition (32)
Spinal muscular atrophy (147)
Sponsored (51)
Startups (2642)
State (1)
Stem cells (8)
Stomach cancer (16)
Substance use disorders (21)
Supply chain (120)
Switzerland (23)
Tariffs (75)
Tax incentives (1)
The Weekly (113)
Vaccines (1059)
Venture capital (148)
Weight loss (439)
Wet AMD (7)
Women's health (148)
Women in leadership (1)
Worklife (28)
Date
Last 7 days (545)
Last 30 days (2857)
Last 365 days (25072)
2026 (23166)
2025 (24230)
2024 (28384)
2023 (32916)
2022 (42461)
2021 (45759)
2020 (44289)
2019 (36516)
2018 (27663)
2017 (25277)
2016 (23886)
2015 (28265)
2014 (20845)
2013 (16665)
2012 (17227)
2011 (17672)
2010 (15429)
Location
Africa (758)
Alabama (80)
Alaska (6)
Arizona (266)
Arkansas (11)
Asia (38696)
Australia (6308)
California (13094)
Canada (4108)
China (1757)
Colorado (599)
Connecticut (595)
Delaware (465)
Europe (74766)
Florida (1901)
Georgia (420)
Hawaii (4)
Idaho (41)
Illinois (1049)
India (122)
Indiana (615)
Iowa (30)
Japan (694)
Kansas (122)
Kentucky (41)
Louisiana (51)
Maine (94)
Maryland (1640)
Massachusetts (9213)
Michigan (338)
Minnesota (634)
Mississippi (5)
Missouri (147)
Montana (26)
Nebraska (18)
Nevada (147)
New Hampshire (66)
New Jersey (3809)
New Mexico (26)
New York (3531)
North Carolina (1596)
North Dakota (10)
Northern California (6842)
Ohio (396)
Oklahoma (20)
Oregon (40)
Pennsylvania (2395)
Puerto Rico (22)
Rhode Island (37)
South America (943)
South Carolina (75)
Southern California (5269)
Tennessee (172)
Texas (2097)
United States (46042)
Utah (420)
Vermont (2)
Virginia (368)
Washington D.C. (51)
Washington State (991)
West Virginia (3)
Wisconsin (126)
Wyoming (4)
539,572 Results for "can fite biopharma ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Can-Fite Announces Eurasian Patent Allowance Supporting Piclidenoson Development and Commercialization in Lowe Syndrome
November 2, 2026
·
9 min read
Press Releases
Can-Fite Reports Ten-Year Survival Milestone for Advanced Liver Cancer Patient from Phase II Namodenoson Study
November 9, 2026
·
6 min read
Press Releases
Can-Fite Presents Final Positive Data from Phase IIa Pancreatic Cancer Study of Namodenoson at ESMO 2026
October 26, 2026
·
7 min read
Press Releases
Can-Fite to Pursue Global Licensing and Strategic Partnerships at BIO-Europe 2026 Following Recent Clinical and Intellectual Property Milestones
November 6, 2026
·
7 min read
Press Releases
Can-Fite’s Piclidenoson Demonstrates Up to 80% Improvement in Kidney Disease Marker in Lowe Syndrome Preclinical Study: Published in Nature Portfolio Journal
November 12, 2026
·
9 min read
Press Releases
Can-Fite Pivotal Phase III Psoriasis Study Under an FDA- and EMA-agreed protocol: All Patients Completed Dosing and Interim Analysis Expected Q1 2027
November 18, 2026
·
7 min read
Press Releases
Can-Fite: Namodenoson Enhances the Anti-Cancer Effect of Chemotherapy in Pancreatic Cancer
August 17, 2026
·
6 min read
Press Releases
Can-Fite: Publication Reports Improvement in Decompensated Cirrhosis with Namodenoson and Successful Bridging to Liver Transplantation
September 9, 2026
·
7 min read
Press Releases
Can-Fite Reports Longer-Than-Anticipated Overall Survival in Ongoing Pivotal Phase III Liver Cancer Study
September 2, 2026
·
6 min read
Press Releases
Can-Fite Highlights Advanced FDA and EMA Regulatory Status of its Phase III Drug Candidates
August 12, 2026
·
6 min read
1 of 53,958
Next